Asthalin HFA Inhaler 200 MD 100 mcg Cipla
€19.00
About Asthalin HFA Inhaler 200 MD 100 mcg Cipla, purpose and chemical nature
The Asthalin HFA Inhaler 200 MD 100 mcg Cipla is a widely recognized bronchodilator used primarily in the management of asthma and chronic obstructive pulmonary disease (COPD). This inhaler contains the active ingredient salbutamol, which is a selective beta-2 adrenergic agonist. Salbutamol works by relaxing the smooth muscles in the airways, leading to increased airflow and enhanced lung function. The Chemical designation of salbutamol is (R)-2-(4-hydroxy-3-(hydroxymethyl) phenyl) – 1, 2, 3, 4-tetrahydronaphthalen-1-ol, indicating a complex molecular structure that is essential for its pharmacological effects. The HFA (hydrofluoroalkane) propellant used in this inhaler is designed to be more environmentally friendly than traditional propellants, contributing to an effective delivery system while minimizing environmental impact.
Mechanism of action, internal processes in the body
When a patient utilizes the Asthalin HFA Inhaler, salbutamol is rapidly delivered into the respiratory system. Upon inhalation, salbutamol binds to beta-2 receptors located on the smooth muscle cells of the bronchial passages. This binding activates adenylate cyclase, which increases levels of cyclic AMP (cAMP) in the cells. Increased cAMP levels facilitate the relaxation of bronchial smooth muscle through various intracellular mechanisms, including the inhibition of myosin light chain kinase activity. This smooth muscle relaxation significantly dilates the airways, thereby enhancing airflow and alleviating symptoms of wheezing and shortness of breath associated with conditions like asthma and COPD. Furthermore, the onset of action is typically within minutes, providing a rapid relief for patients experiencing acute bronchospasm.
Side effects, how to prevent them
While the Asthalin HFA Inhaler is generally well-tolerated, some patients may experience side effects such as tremors, palpitations, headache, or throat irritation. These effects can often be attributed to the drug’s stimulant properties on the cardiovascular system or its local impact on the respiratory tract. To mitigate the occurrence of side effects, it is crucial for users to adhere strictly to the recommended dosage and frequency of inhalation. Patients should also consult their healthcare provider to ensure that the use of this bronchodilator is suitable for their specific health profile, particularly if they have underlying heart conditions or are taking other medications that might interact with salbutamol. Staying hydrated and practicing good inhalation techniques can also help improve drug delivery and minimize throat irritation.
How to Buy Asthalin HFA Inhaler 200 MD 100 mcg Cipla in Great Britain, verified seller and guarantees
Purchasing the Asthalin HFA Inhaler 200 MD 100 mcg Cipla in Great Britain can be accomplished through several channels. The most reliable means is via online pharmacies that require a valid prescription from a licensed healthcare provider. It is crucial to choose verified sellers that are registered with the General Pharmaceutical Council (GPhC) for quality assurance. When ordering online, ensure that the pharmacy provides clear contact information and transparent privacy policies. Authentic pharmacies often have customer support services for any inquiries related to the medication. Patients should also look for customer reviews and testimonies to verify the seller’s credibility. Additionally, keep an eye on guarantees concerning product quality and delivery, as reputable sellers will often offer refunds or exchanges in case of any issues with the product.
Results and conclusions, summary of user experience
Overall, user experiences with the Asthalin HFA Inhaler have been largely positive, particularly in terms of its effectiveness in managing asthma and COPD symptoms. Many users have reported quick relief from symptoms, allowing them to engage in physical activities, including sports, with greater ease. However, some users have expressed concerns regarding occasional side effects, echoing the need for proper drug administration and monitoring. Overall, this inhaler stands as a beneficial tool for respiratory management, helping to improve quality of life for those with obstructive airway conditions. It is important for users to follow medical advice, monitor their response to the medication, and maintain regular check-ups with healthcare providers to ensure optimal management of their respiratory health.
| Active substance | Salbutamol |
|---|---|
| Water Retention | None |
| Hepatotoxicity | None reported |
| Lab Test | Detection via urine analysis for anti-doping purposes |
| Strength | 100mcg |
| Also known as | Ventolin |
| Blood pressure | Can cause transient increases in blood pressure |
| Trade name | Ventolin, Proventil, Albuterol |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (RS)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol |
| Formula | C13H21NO3 |
| Substance class | Beta2-adrenergic agonist |
| Main action | Bronchodilation |
| Half-life | 4 to 6 hours |
| Dosage (medical) | 2-4 mg orally or 100-200 mcg via inhalation every 4-6 hours |
| Dosage (sports) | Not applicable as salbutamol is primarily used for medical purposes |
| Effects | Relaxation of bronchial smooth muscle, increased airflow to the lungs |
| Side effects | Tremor, headache, palpitations, rapid heart rate |
| Use in sports | Prohibited above certain thresholds by anti-doping agencies, used for asthma management in athletes with a therapeutic use exemption |
| Manufacturer | Cipla Ltd. |
| Packing | 1 Inhaler/pack |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |














Reviews
There are no reviews yet.